Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

fludarabine 5Cyclophosphamide 5Cyclosporine 4fludarabine phosphate 3Whole-Body Irradiation 3Imatinib Mesylate 3Therapeutics 2Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Methotrexate 2Hematologic Tests 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1nilotinib 1bosutinib 1Urinalysis 1Transplantation, Homologous 1Tetanus Toxoid 1Standard of Care 1Resistance Training 1Registries 1Radiotherapy 1Pharmaceutical Services 1Ondansetron 1Nurse Clinicians 1Modafinil 1Melphalan 1Health Promotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Registries × Clear all
NCT00538447 2011-12-13

Prospective Database for Chronic Myelogenous Leukemia

King Faisal Specialist Hospital & Research Center

Phase NA Unknown
2,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡